Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study

Basit Öğe Kaydı
dc.authoridCavdar, Eyyup/0000-0001-5885-3047
dc.authoridgülmez, ahmet/0000-0002-3353-344X
dc.authoridkubilay, pınar/0000-0003-2636-5326
dc.authoridŞenocak Taşçı, Elif/0000-0002-1686-1628
dc.authoridDoğan, İzzet/0000-0003-1018-1119
dc.authorwosidunal, olcun umit/IST-6684-2023
dc.authorwosidKarakurt, Melek/AAO-5495-2020
dc.authorwosidCavdar, Eyyup/HDM-3862-2022
dc.authorwosidgülmez, ahmet/ABI-8218-2020
dc.authorwosidkubilay, pınar/JVP-3454-2024
dc.authorwosidErdogan, Atike Pinar/AFC-3012-2022
dc.authorwosidŞenocak Taşçı, Elif/KBD-3048-2024
dc.contributor.authorOzgun, M. A.
dc.contributor.authorDogan, I.
dc.contributor.authorEryilmaz, M. Karakurt
dc.contributor.authorErdogan, A. P.
dc.contributor.authorAyhan, M.
dc.contributor.authorHafizoglu, E.
dc.contributor.authorTolunay, P. K.
dc.date.accessioned2024-06-12T11:20:21Z
dc.date.available2024-06-12T11:20:21Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.descriptionCongress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 16-21, 2021 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.identifier.doi10.1016/j.annonc.2021.08.1461
dc.identifier.endpageS892en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpageS892en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2021.08.1461
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25575
dc.identifier.volume32en_US
dc.identifier.wosWOS:000700527702094en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleReal-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group studyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu